Literature DB >> 11286831

CT and (18)F-deoxyglucose (FDG) image fusion for optimization of conformal radiotherapy of lung cancers.

P Giraud1, D Grahek, F Montravers, M F Carette, E Deniaud-Alexandre, F Julia, J C Rosenwald, J M Cosset, J N Talbot, M Housset, E Touboul.   

Abstract

PURPOSE: To validate a computed tomography (CT) and (18)F-deoxyglucose (FDG) image fusion procedure and to evaluate its usefulness to facilitate target definition and treatment planning in three-dimensional conformal radiation therapy (3D-CRT) for non-small-cell lung cancer. METHODS AND MATERIALS: Twelve patients were assessed by CT and FDG-coincidence mode dual-head gamma camera (CDET) before radiotherapy. The patients were placed in a similar position during CT and FDG-CDET. Matching was achieved by minimizing the cost function by 3D translation and rotation between four landmarks drawn on the patient's skin. Virtual simulation was performed from image fusion and estimated dose-volume histograms (DVH) were calculated.
RESULTS: Quantitative analysis indicated that the matching error was < 5 mm. Fusion of anatomic and metabolic data corrected staging of lymph nodes (N) for 4 patients and staging of metastases for 1 patient. In these 5 patients, DVH revealed that the lung volume irradiated at 20 Gy (Vl(20)) was decreased by an average of 22.8%, and tumor volume irradiated at the 95% isodose (V(95)) was increased by 22% and 8% for 2 patients, respectively, and was decreased by an average of 59% for 3 patients after fusion. No difference in terms of Vl(20) and V(95) was observed for the other 7 patients.
CONCLUSION: We have validated CT and FDG-CDET lung image fusion to facilitate determination of lung cancer volumes, which improved the accuracy of 3D-CRT.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11286831     DOI: 10.1016/s0360-3016(00)01579-0

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  18 in total

Review 1.  PET/CT and breast cancer.

Authors:  Barbara Zangheri; Cristina Messa; Maria Picchio; Luigi Gianolli; Claudio Landoni; Ferruccio Fazio
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-05-05       Impact factor: 9.236

2.  The role of molecular imaging in precision radiation therapy for target definition, treatment planning optimisation and quality control.

Authors:  Giovanni Lucignani; Barbara A Jereczek-Fossa; Roberto Orecchia
Journal:  Eur J Nucl Med Mol Imaging       Date:  2004-03-30       Impact factor: 9.236

3.  The Netherlands protocol for standardisation and quantification of FDG whole body PET studies in multi-centre trials.

Authors:  Ronald Boellaard; Wim J G Oyen; Corneline J Hoekstra; Otto S Hoekstra; Eric P Visser; Antoon T Willemsen; Bertjan Arends; Fred J Verzijlbergen; Josee Zijlstra; Anne M Paans; Emile F I Comans; Jan Pruim
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-15       Impact factor: 9.236

4.  Computer-aided diagnosis systems for lung cancer: challenges and methodologies.

Authors:  Ayman El-Baz; Garth M Beache; Georgy Gimel'farb; Kenji Suzuki; Kazunori Okada; Ahmed Elnakib; Ahmed Soliman; Behnoush Abdollahi
Journal:  Int J Biomed Imaging       Date:  2013-01-29

5.  Radiotherapy planning: PET/CT scanner performances in the definition of gross tumour volume and clinical target volume.

Authors:  Ernesto Brianzoni; Gloria Rossi; Sergio Ancidei; Alfonso Berbellini; Francesca Capoccetti; Carla Cidda; Paola D'Avenia; Sara Fattori; Gian Carlo Montini; Gianluca Valentini; Alfredo Proietti; Carlo Algranati
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-08-26       Impact factor: 9.236

6.  Target volume definition for 18F-FDG PET-positive lymph nodes in radiotherapy of patients with non-small cell lung cancer.

Authors:  Ursula Nestle; Andrea Schaefer-Schuler; Stephanie Kremp; Andreas Groeschel; Dirk Hellwig; Christian Rübe; Carl-Martin Kirsch
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-10-21       Impact factor: 9.236

7.  Variabilities of Magnetic Resonance Imaging-, Computed Tomography-, and Positron Emission Tomography-Computed Tomography-Based Tumor and Lymph Node Delineations for Lung Cancer Radiation Therapy Planning.

Authors:  Kishor Karki; Siddharth Saraiya; Geoffrey D Hugo; Nitai Mukhopadhyay; Nuzhat Jan; Jessica Schuster; Matthew Schutzer; Lester Fahrner; Robert Groves; Kathryn M Olsen; John C Ford; Elisabeth Weiss
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-06       Impact factor: 7.038

Review 8.  State-of-the-art molecular imaging in esophageal cancer management: implications for diagnosis, prognosis, and treatment.

Authors:  Jolinta Lin; Seth Kligerman; Rakhi Goel; Payam Sajedi; Mohan Suntharalingam; Michael D Chuong
Journal:  J Gastrointest Oncol       Date:  2015-02

Review 9.  Role and cost effectiveness of PET/CT in management of patients with cancer.

Authors:  Muhammad Wasif Saif; Ifigenia Tzannou; Nektaria Makrilia; Kostas Syrigos
Journal:  Yale J Biol Med       Date:  2010-06

10.  (18)F-fluorodeoxyglucose positron emission tomography-based assessment of local failure patterns in non-small-cell lung cancer treated with definitive radiotherapy.

Authors:  Sonal Sura; Carlo Greco; Daphna Gelblum; Ellen D Yorke; Andrew Jackson; Kenneth E Rosenzweig
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.